205 related articles for article (PubMed ID: 20634194)
41. Src signaling pathways in prostate cancer.
Varkaris A; Katsiampoura AD; Araujo JC; Gallick GE; Corn PG
Cancer Metastasis Rev; 2014 Sep; 33(2-3):595-606. PubMed ID: 24522479
[TBL] [Abstract][Full Text] [Related]
42. Current status of SRC inhibitors in solid tumor malignancies.
Puls LN; Eadens M; Messersmith W
Oncologist; 2011; 16(5):566-78. PubMed ID: 21521831
[TBL] [Abstract][Full Text] [Related]
43. Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors.
Park SI; Shah AN; Zhang J; Gallick GE
Expert Opin Ther Targets; 2007 Sep; 11(9):1207-17. PubMed ID: 17845146
[TBL] [Abstract][Full Text] [Related]
44. The evolving landscape of protein kinases in breast cancer: clinical implications.
Ocaña A; Amir E; Seruga B; Martin M; Pandiella A
Cancer Treat Rev; 2013 Feb; 39(1):68-76. PubMed ID: 22703833
[TBL] [Abstract][Full Text] [Related]
45. SRC kinase inhibitors: an update on patented compounds.
Schenone S; Brullo C; Musumeci F; Radi M; Castagnolo D
Curr Med Chem; 2011; 18(33):5061-78. PubMed ID: 22050754
[TBL] [Abstract][Full Text] [Related]
46. SRC inhibitors and angiogenesis.
Schenone S; Manetti F; Botta M
Curr Pharm Des; 2007; 13(21):2118-28. PubMed ID: 17627544
[TBL] [Abstract][Full Text] [Related]
47. The role of Src in solid tumors.
Wheeler DL; Iida M; Dunn EF
Oncologist; 2009 Jul; 14(7):667-78. PubMed ID: 19581523
[TBL] [Abstract][Full Text] [Related]
48. SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.
Johnson FM; Gallick GE
Anticancer Agents Med Chem; 2007 Nov; 7(6):651-9. PubMed ID: 18045060
[TBL] [Abstract][Full Text] [Related]
49. Src kinase and pancreatic cancer.
Hilbig A
Recent Results Cancer Res; 2008; 177():179-85. PubMed ID: 18084959
[TBL] [Abstract][Full Text] [Related]
50. Traditional Chinese Medicine Targeting Sarcoma Virus Oncogene-related Diseases.
Wang Y; Wang X; Su K; Yang Y
Curr Cancer Drug Targets; 2023; 23(10):751-763. PubMed ID: 37170983
[TBL] [Abstract][Full Text] [Related]
51. Src tyrosine kinase as a chemotherapeutic target: is there a clinical case?
Chen T; George JA; Taylor CC
Anticancer Drugs; 2006 Feb; 17(2):123-31. PubMed ID: 16428929
[TBL] [Abstract][Full Text] [Related]
52. Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic response.
Donington JS; Le QT; Wakelee HA
Clin Lung Cancer; 2006 Jul; 8(1):22-9. PubMed ID: 16870042
[TBL] [Abstract][Full Text] [Related]
53. SRC Signaling in Cancer and Tumor Microenvironment.
Caner A; Asik E; Ozpolat B
Adv Exp Med Biol; 2021; 1270():57-71. PubMed ID: 33123993
[TBL] [Abstract][Full Text] [Related]
54. Antiangiogenesis strategies proving valuable against breast and prostate cancer.
Oncology (Williston Park); 1997 Sep; 11(9):1358. PubMed ID: 9306424
[No Abstract] [Full Text] [Related]
55. Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting.
Rao S; Thibault B; Peyrard L; Larroque-Lombard AL; Rupp M; Thauvin C; Jean-Claude BJ
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502481
[TBL] [Abstract][Full Text] [Related]
56. Drugs for solid cancer: the productivity crisis prompts a rethink.
Rösel D; Brábek J; Veselý P; Fernandes M
Onco Targets Ther; 2013; 6():767-77. PubMed ID: 23836990
[TBL] [Abstract][Full Text] [Related]
57. Targeting Src family kinases in anti-cancer therapies: turning promise into triumph.
Zhang S; Yu D
Trends Pharmacol Sci; 2012 Mar; 33(3):122-8. PubMed ID: 22153719
[TBL] [Abstract][Full Text] [Related]
58. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.
Roskoski R
Pharmacol Res; 2015 Apr; 94():9-25. PubMed ID: 25662515
[TBL] [Abstract][Full Text] [Related]
59. A versatile engineered extracellular vesicle platform simultaneously targeting and eliminating senescent stromal cells and tumor cells to promote tumor regression.
Gong L; Chen Z; Feng K; Luo L; Zhang J; Yuan J; Ren Y; Wang Y; Zheng X; Li Q
J Nanobiotechnology; 2024 Mar; 22(1):105. PubMed ID: 38468249
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
